OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A.

Corporate taxpayer ID (CNPJ/MF) 20.258.278/0001-70

Corporate Registration Number (NIRE) 35.300.465.415

MATERIAL FACT

Signing of Shareholders' Agreement and Acquisition of Relevant Shareholding Interest

OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. ("Company"), pursuant to CVM (Comissão de Valores Mobiliários) Instruction 358, dated January 3, 2002, as amended ("ICVM nº 358") and in compliance with Paragraph 4 of Section 157 of Law 6404, dated December 15, 1976, as amended ("Brazilian Corporations Law"), hereby announces to its shareholders and the market in general that recieved from G.A. BRASIL VII FUNDO DE INVESTIMENTO EM PARTICIPAÇÕES MULTIESTRATÉGIA, corporate taxpayer ID (CNPJ/MF) numbered 21.120.650/0001-40("FIP GA") in the present date a correspondence informing that it has sold the totality of its participation in the Company's capital stock.

The Company informs that it received in the present date also a correspondence from funds managed by OPPORTUNITY HDF ADMINISTRADORA DE RECURSOS LTDA, corporate taxpayer ID (CNPJ/MF) numbered 33.857.830/0001-99 (hereinafter collectively referred to as "Investors"), informing to the Company that they acquired in a private deal carried out outside the stock exchange (B3) the amount of 9,138,407 common shares (OFSA3) issued by the Company equivalent to 16.94% of the total of common shares issued by the Company and linked to the Shareholders' Agreement.

In addition to the provisions above, the Company informs that a Shareholder' Agreement was signed and filed on this date in the Company's headquarters in compliance with Section 118 of the Brazilian Corporations Law between the Investors and current Company sharelholders Mr. Jardel Massari and Mr. Norival Bonamichi whose terms and conditions are substantially similar to those provided for in the Shareholders' Agreement previously signed between the main shareholders of Company and GA LATIN AMERICA INVESTMENTS, LLC.

The Company informs that, due to the sale of the entire participation of FIP GA in the Company's capital stock, the Shareholders' Agreement, signed on September 26, 2014, between GA LATIN AMERICA INVESTMENTS, LLC and Mr. Jardel Massari and Mr. Norival Bonamichi, with the intervention of the Company, was automatically terminated in their own right.

Finally, due to the transaction hereby announced, the Company informs that Mr. Rodrigo de Almeida Prado Catunda and Mr. Frederico Seabra de Carvalho submitted their letters of resignation to the positions of Member of the Board of Directors and Member of the Audit Committee, respectively. The Company is grateful for the relevant contributions and work developed by them in their respective mandates and informs that its Board of Directors will meet to take measures for the substitutes.

The Company's Investor Relations Department remains at the disposal of shareholders to clarify any issues related to the subject of this material fact.

Cravinhos, August 13th, 2020.

Marcelo da Silva

Chief Finance and Investor Relations Officer

Attachments

  • Original document
  • Permalink

Disclaimer

Ourofino Saúde Animal Participações SA published this content on 13 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 August 2020 22:02:09 UTC